CTI is Pleased to Announce the Receipt of a Patent
LOS ANGELES, Sept. 29 /PRNewswire/ — Cavitation Technologies, Inc. (CTI) (OTC Bulletin Board: CVAT & Berlin/Stuttgart: WTC) is pleased to announce the receipt of Patent 7,762,715.
“This patent marks a milestone in building our patent portfolio,” states Roman Gordon, CEO of CTI. This broadened IP is another step towards accelerating business development in the U.S. and around the world.
The current patent relates to a method for processing a fluidic mixture in a multi-stage hydrodynamic cavitation device and is used for processing heterogeneous fluids by the controllable formation of cavitation bubbles.
About Cavitation Technologies, Inc.
Cavitation Technologies, Inc (CTI). is a “Green-Tech” company, established in 2006. CTI designs and engineers NANO Technology based skid systems that are designed to serve growing markets such as edible oil refining, renewable fuels, crude oil yield enhancement, water-fuel emulsions, water purification and algae oil extraction. R&D has led to products including the Green D+Plus NANO Neutralization System - a vegetable oil refining system, and the Bioforce 9000 NANO Reactor System which performs the transeseterification process during the production of biodiesel. Both the Green D+Plus System and the Bioforce 9000 NANO Reactor System employ our proprietary, continuous flow-through, hydrodynamic NANO Technology in the form of our multi-stage NANO Series of reactors. The Green D+ Plus System is currently in commercial operation at Carolina Soya, LLC, a vegetable oil refining facility located in South Carolina. Paul E. Hankey Jr., General Manager of Carolina Soya recently stated: “The operation of the Green D+ Plus NANO Refining System has been straightforward and simple…and will continue to be a significant process improvement for our refinery.” For additional information please visit: www.cavitationtechnologies.com
Safe Harbor: Pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Exchange Act of 1934, any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals and assumptions of future events or performance are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this release may be identified through the use of words such as “expects,” “will,” “anticipates,” “estimates,” “believes,” or statements indicating certain actions such as “may,” “could,” or “might” occur. Such statements reflect the current views of CTI with respect to future events and are subject to certain assumptions, including those described in this release. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products, services, and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. Cavitation Technologies, Inc. does not undertake any responsibility to update the “forward-looking” statements contained in this news release.
SOURCE Cavitation Technologies, Inc.